Effectively, you would be injecting a solution that has little to no active medication left, which can lead to a stall in your weight loss progress
@ADA_Pubs Read Here doi.org/10.2337/dc25-0 In FLOW, semaglutide, a GLP-1 RA, reduced the risk of major kidney outcomes, MACE and all-cause mortality in people with T2D and CKD, regardless of baseline mineralocorticoid receptor antagonist use
If you want full pharmacy transparency, Gimme Care wont satisfy you
doi:10.1111/j.1463-1326.2012.01610.x 148
This is why many patients start with compounded semaglutide while the PA process runs in the background
This study aimed to compare durability of treatment efficacy of once-weekly (OW) semaglutide for T2D with that of the dipeptidyl peptidase 4 inhibitor (DPP4i) class